ZDHHC11 and Zika virus infectious disease: A study confirmed that a palmitoylation inhibitor 2-bromopalmitate enhanced ZIKV infection, which subsequently led to the identification of ZDHHC11 as a key enzyme of E protein palmitoylation [82].